Delivery Order SPE2DB22D2211-SPE2DB25FSBFV
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,550.56 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 18, 2025. The contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a $16,048.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Naloxone 2mg/2mL (10-pack units) on July 28, 2025, with completion targeted for August 22, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical with a potential value of $2,480.47. The contract is for the delivery of 25 units of 10 ml naloxone, a critical opioid overdose reversal medication, to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of naloxone 0.4 mg/ml vials. The contract has a total ceiling value of $1,761.46 and is a firm fixed-price type contract. The period of performance extends through June 21, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of naloxone 0.4 mg/ml vials. The award has a ceiling value of $1,815.13 and is a firm fixed-price contract. The order is placed under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on July 24, 2025, with a ceiling value of $1,583.26 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under the company's larger indefinite delivery vehicle with DLA. This delivery order falls...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $3,707.54 delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide naloxone hydrochloride. The firm fixed price contract has a completion date of February 5, 2024. This award is under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $9,921.88 by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,563,719,275 units of NALOXONE 10ML 25S, a pharmaceutical product. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and operates out of its Corporate Office in Conshohocken, Pennsylvania. This award is part of a larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,301.63 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray (2-pack units) on July 23, 2025, with completion required by July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,557,196,796 units of Naloxone HCL 2ML 10S, a critical pharmaceutical product, with a potential value of $10,490.35. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBFVDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $5,434.06. The contract employs firm fixed-price pricing and is classified as a non-set-aside competitive award. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader IDC vehicle enables the company to supply a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic areas to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This specific Naloxone order reflects the company's role in supporting emergency medical supplies within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/21/25 |